Room A
Wed, 08.12.2021
14:30 - 16:00
Date
Wed, 08.12.2021
Time
14:30 - 16:00
Location
Room A
Chairs
- Thomas B. Powles (London, GB)
Future of adjuvant and neoadjuvant treatment (ID 1)
Educational session
What are the right surrogate endpoints for peri-operative immune therapy (ID 3)
Lecture Time
14:30 - 14:50
Speakers
- Thomas B. Powles (London, GB)
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
14:30 - 16:00
Authors
- Thomas B. Powles (London, GB)
Future of adjuvant and neoadjuvant treatment (ID 1)
Educational session
What are the long terms risk of peri-operative immune therapy and how much benefit is required to offset this? (ID 4)
Lecture Time
14:50 - 15:10
Speakers
- Brian I. Rini (Nashville, US)
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
14:30 - 16:00
Authors
- Brian I. Rini (Nashville, US)
Future of adjuvant and neoadjuvant treatment (ID 1)
Educational session
Biomarkers for immune checkpoint inhibitors in the perioperative setting in breast cancer (ID 5)
Lecture Time
15:10 - 15:30
Speakers
- Michail Ignatiadis (Brussels, BE)
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
14:30 - 16:00
Authors
- Michail Ignatiadis (Brussels, BE)
Future of adjuvant and neoadjuvant treatment (ID 1)
Educational session
Exploring beyond PD-(L)1 therapy in peri-operative disease (ID 6)
Lecture Time
15:30 - 15:50
Speakers
- David F. McDermott (Boston, US)
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
14:30 - 16:00
Authors
- David F. McDermott (Boston, US)
Future of adjuvant and neoadjuvant treatment (ID 1)
Educational session
Q&A (ID 7)
Lecture Time
15:50 - 16:00
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 08.12.2021
Time
14:30 - 16:00